| 1 | Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2. (Chong Teo KY, Sadda SR, Gemmy Cheung CM, Chakravarthy U, Staurenghi G, Invernizzi A, Ogura Y, Ruamviboonsuk P, Chen SJ, Gupta V, Tan C, Chhablani J, Corvi F, Kim JE, Gomi F, Koh AH, Kokame G, Mitchell P, Wong TY, Lee WK, Lai TYY) Ophthalmol Retina 2021 Oct;5(10):945-953 13 Citations |
| 2 | Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination. (Quirk B, Olasz E, Kumar S, Basel D, Whelan H) Photobiomodul Photomed Laser Surg 2021 Jun;39(6):411-417 4 Citations |
| 1 | Photodynamic therapy for the treatment of tracheobronchial papillomatosis: A multicenter experience. (Glisinski K, Kurman JS, Spandorfer A, Pastis NJ, Murgu S, Cheng GZ) Photodiagnosis Photodyn Ther 2020 Jun;30:101711 1 Citation |
| 1 | Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. (Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA) J Am Acad Dermatol 2020 Jan;82(1):161-201 87 Citations |
| 1 | NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. (Chen H, Zeng X, Tham HP, Phua SZF, Cheng W, Zeng W, Shi H, Mei L, Zhao Y) Angew Chem Int Ed Engl 2019 Jun 03;58(23):7641-7646 107 Citations |
| 1 | Is Photodynamic Therapy Resistance a Special Case of Photobiomodulation? (Quirk BJ, Girotti AW, Whelan HT) Photomed Laser Surg 2018 Aug;36(8):397-398 2 Citations |
| 1 | Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1. (Fahey JM, Stancill JS, Smith BC, Girotti AW) J Biol Chem 2018 Apr 06;293(14):5345-5359 33 Citations |
| 1 | Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. (Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D) ACS Nano 2017 Feb 28;11(2):2227-2238 350 Citations |
| 1 | Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model. (Fahey JM, Emmer JV, Korytowski W, Hogg N, Girotti AW) Photochem Photobiol 2016 Nov;92(6):842-853 30 Citations |
| 1 | Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease? (Traul DL, Sieber F) J Photochem Photobiol B 2015 Dec;153:153-63 12 Citations |
| 5 | Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? (Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT) Photodiagnosis Photodyn Ther 2015 Sep;12(3):530-44 150 Citations |
| 1 | Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. (Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A) Int J Nanomedicine 2015;10:125-45 26 Citations |
| 1 | Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. (Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF, Macula Society CSC Collaborative Study Group, Research and Education Committee and Website Committee) Ophthalmology 2014 May;121(5):1073-8 110 Citations |
| 2 | A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. (Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EEW, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E) Oral Oncol 2013 Sep;49(9):970-976 21 Citations |
| 1 | Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: an individual patient data analysis of 2 phase 3 trials. (Weinberg DV, Shapiro H, Ehrlich JS) Ophthalmology 2013 Jun;120(6):1278-82 13 Citations |
| 1 | Core curriculum for EMR and ablative techniques. (Training Committee 2010-2012, Hunt GC, Coyle WJ, Pais SA, Adler DG, Degregorio B, Dimaio CJ, Dua KS, Enestvedt BK, Lee LS, McHenry L Jr, Mullady DK, Rajan E, Sedlack RE, Shami VM, Tierney WM, Faulx AL) Gastrointest Endosc 2012 Oct;76(4):725-9 8 Citations |
| 1 | Photochemically generated elemental selenium forms conjugates with serum proteins that are preferentially cytotoxic to leukemia and selected solid tumor cells. (Daziano JP, Günther WH, Krieg M, Tsujino I, Miyagi K, Anderson GS, Sampson RW, Ostrowski MD, Muir SA, Bula RJ, Sieber F) Photochem Photobiol 2012;88(2):448-60 9 Citations |
| 1 | Hexaminolevulinate-mediated photodynamic purging of marrow grafts with murine breast carcinoma. (Čunderlíková B, Vasovič V, Sieber F, Furre T, Borgen E, Nesland JM, Peng Q) Bone Marrow Transplant 2011 Aug;46(8):1118-27 10 Citations |
| 1 | Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients? (Belostotsky I, da Silva SM, Paez MG, Indig GL) Biotech Histochem 2011 Oct;86(5):302-14 14 Citations |
| 1 | The use of sham controls in clinical trials. (Weinberg DV) Arch Ophthalmol 2010 May;128(5):647-8; author reply 648 |
| 1 | Hexaminolevulinate-mediated photodynamic purging of leukemia cells from BM. (Čunderlíková B, Vasovič V, Sieber F, Furre T, Nesland JM, Peng Q) Bone Marrow Transplant 2010 Oct;45(10):1553-61 5 Citations |
| 1 | Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. (Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JYM, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R) J Am Acad Dermatol 2010 Jan;62(1):114-135 294 Citations |
| 4 | Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation. (Han DP, McAllister JT, Weinberg DV, Kim JE, Wirostko WJ) Eye (Lond) 2010 Apr;24(4):713-6 16 Citations |
| 1 | Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. (Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group) Arch Ophthalmol 2009 Jan;127(1):13-21 85 Citations |
| 1 | Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. (Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group) Ophthalmology 2009 Jan;116(1):57-65.e5 1112 Citations |
| 1 | Treatment of choroidal neovascularization in AMD. (Weinberg DV, Jampol LM) Ophthalmology 2006 Dec;113(12):2372; author reply 2372-3 |
| 1 | Recurrent bullous retinal detachments from photodynamic therapy for idiopathic polypoidal choroidal vasculopathy. (Prakash M, Han DP) Am J Ophthalmol 2006 Dec;142(6):1079-81 6 Citations |
| 1 | Ranibizumab versus verteporfin for neovascular age-related macular degeneration. (Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group) N Engl J Med 2006 Oct 05;355(14):1432-44 3040 Citations |
| 1 | Clinical inquiries. What nonpharmacological treatments are effective against common nongenital warts? (Abernethy H, Cho C, DeLanoy A, Khan O, Kerns JW, Knight K, Diehr S) J Fam Pract 2006 Sep;55(9):801-2 4 Citations |
| 1 | Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B. (Tsujino I, Miyagi K, Sampson RW, Sieber F) Photochem Photobiol 2006;82(2):458-65 19 Citations |
| 1 | Photodynamic therapy for extrafoveal choroidal neovascularization associated with choroidal nevus. (Moon SJ, Wirostko WJ) Retina 2006 Apr;26(4):477-9 4 Citations |
| 1 | Photophysical, photochemical, and tumor-selectivity properties of bromine derivatives of rhodamine-123. (Lacerda SH, Abraham B, Stringfellow TC, Indig GL) Photochem Photobiol 2005;81(6):1430-8 23 Citations |
| 1 | Pegaptanib for neovascular age-related macular degeneration. (Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group) N Engl J Med 2004 Dec 30;351(27):2805-16 2130 Citations |
| 1 | Exudative complications after photodynamic therapy. (Holz ER, Linares L, Mieler WF, Weinberg DV) Arch Ophthalmol 2003 Nov;121(11):1649-52 22 Citations |
| 1 | Crystal violet combined with Merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts. (Miyagi K, Sampson RW, Sieber-Blum M, Sieber F) J Photochem Photobiol B 2003 Jul;70(3):133-44 13 Citations |
| 1 | Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts. (Anderson GS, Tsujino I, Miyagi K, Sampson R, Sieber F) J Photochem Photobiol B 2003 Feb;69(2):87-95 24 Citations |
| 1 | Safe use of pulse oximetry during verteporphin therapy. (Woehlck H, Herrmann D, Kaslow O) Anesth Analg 2003 Jan;96(1):177-8, table of contents 6 Citations |
| 1 | Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. (Anderson GS, Miyagi K, Sampson RW, Sieber F) J Photochem Photobiol B 2002 Nov;68(2-3):101-8 24 Citations |
| 1 | A potentially life-threatening adverse reaction to verteporfin. (Noffke AS, Jampol LM, Weinberg DV, Muñana A) Arch Ophthalmol 2001 Jan;119(1):143 16 Citations |
| 1 | Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal photochemotherapy. (Tsujino I, Sieber F) Photochem Photobiol 2000 Dec;72(6):810-4 4 Citations |
| 2 | Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells. (Indig GL, Anderson GS, Nichols MG, Bartlett JA, Mellon WS, Sieber F) J Pharm Sci 2000 Jan;89(1):88-99 71 Citations |
| 1 | Physico-chemical modeling of the role of free radicals in photodynamic therapy. IV. Quantitative aspects of photodynamic effects on free radicals generated in cell cultures. (Németh A, Jakus J, Kriska T, Keszler A, Vanyur R, Gál D) Biochem Biophys Res Commun 1999 Feb 16;255(2):360-6 11 Citations |
| 1 | Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. (Yamazaki T, Sato Y, Sieber F) Exp Hematol 1997 Jul;25(7):629-37 21 Citations |
| 1 | Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs. (Traul DL, Anderson GS, Bilitz JM, Krieg M, Sieber F) Photochem Photobiol 1995 Oct;62(4):790-9 6 Citations |
| 2 | Enhancement of merocyanine 540 uptake and photodynamic cell killing by salicylates. (Feix JB, Anderson MS, Kalyanaraman B) Cancer Res 1994 Jul 01;54(13):3474-8 4 Citations |
| 1 | Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts. (Sieber F, Gaffney DK, Yamazaki T, Qiu K) Prog Clin Biol Res 1994;389:147-54 2 Citations |
| 3 | The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. (Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA) J Neurosurg 1993 Oct;79(4):562-8 49 Citations |
| 1 | Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT. (Itoh T, Messner HA, Jamal N, Tweeddale M, Sieber F) Bone Marrow Transplant 1993 Sep;12(3):191-6 26 Citations |
| 2 | Enhancement of merocyanine 540-mediated phototherapy by salicylate. (Anderson MS, Kalyanaraman B, Feix JB) Cancer Res 1993 Feb 15;53(4):806-9 10 Citations |
| 1 | Phototherapy, photochemotherapy, and bone marrow transplantation. (Sieber F) J Hematother 1993;2(1):43-62 21 Citations |
| 1 | Limited cell-cycle dependence of the merocyanine 540-sensitized photoinactivation of L1210 leukemia cells. (Qiu K, Traul DL, Sieber F) Photochem Photobiol 1992 Aug;56(2):277-80 2 Citations |
| 1 | Merocyanine 540-sensitized photoinactivation of human erythrocytes parasitized by Plasmodium falciparum. (Smith OM, Dolan SA, Dvorak JA, Wellems TE, Sieber F) Blood 1992 Jul 01;80(1):21-4 19 Citations |
| 1 | Merocyanine 540-sensitized photoinactivation of enveloped viruses in blood products: site and mechanism of phototoxicity. (O'Brien JM, Gaffney DK, Wang TP, Sieber F) Blood 1992 Jul 01;80(1):277-85 58 Citations |
| 3 | Interactions of merocyanine 540 with human brain tumor cells. (Whelan HT, Traul DL, Przybylski C, Segura A, Thomas J, Meyer G, Sieber F) Pediatr Neurol 1992;8(2):117-20 6 Citations |
| 1 | Evaluation of merocyanine 540-sensitized photoirradiation as a method for purging malarially infected red cells from blood. (Smith OM, Traul DL, McOlash L, Sieber F) J Infect Dis 1991 Jun;163(6):1312-7 14 Citations |
| 2 | Photodynamic action of merocyanine 540 in artificial bilayers and natural membranes: action spectra and quantum yields. (Singh RJ, Feix JB, Pintar TJ, Girotti AW, Kalyanaraman B) Photochem Photobiol 1991 Apr;53(4):493-500 37 Citations |
| 1 | Role of lipid peroxidation in hematoporphyrin derivative-sensitized photokilling of tumor cells: protective effects of glutathione peroxidase. (Thomas JP, Girotti AW) Cancer Res 1989 Apr 01;49(7):1682-6 69 Citations |
| 1 | Photodynamic therapy and bone marrow transplantation. (Sieber F, Krueger GJ) Semin Hematol 1989 Jan;26(1):35-9 21 Citations |
| 1 | Dye-mediated photosensitization of murine neuroblastoma cells. (Sieber F, Sieber-Blum M) Cancer Res 1986 Apr;46(4 Pt 2):2072-6 64 Citations |
© 2023 Clinical & Translational Science Institute